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Abstract
Background: Embryonic stem (ES) cells have attracted significant attention from researchers around the world 
because of their ability to undergo indefinite self-renewal and produce derivatives from the three cell lineages, which 
has enormous value in research and clinical applications. Until now, many ES cell lines of different mammals have been 
established and studied. In addition, recently, AS-ES1 cells derived from Apodemus sylvaticus were established and 
identified by our laboratory as a new mammalian ES cell line. Hence further research, in the application of AS-ES1 cells, 
is warranted.
Results: Herein we report the generation of multiple mesodermal AS-ES1 lineages via embryoid body (EB) formation 
by the hanging drop method and the addition of particular reagents and factors for induction at the stage of EB 
attachment. The AS-ES1 cells generated separately in vitro included: adipocytes, osteoblasts, chondrocytes and 
cardiomyocytes. Histochemical staining, immunofluorescent staining and RT-PCR were carried out to confirm the 
formation of multiple mesodermal lineage cells.
Conclusions: The appropriate reagents and culture milieu used in mesodermal differentiation of mouse ES cells also 
guide the differentiation of in vitro AS-ES1 cells into distinct mesoderm-derived cells. This study provides a better 
understanding of the characteristics of AS-ES1 cells, a new species ES cell line and promotes the use of Apodemus ES 
cells as a complement to mouse ES cells in future studies.
Background
Embryonic stem (ES) cells are pluripotent cells derived
from the inner cell mass of blastocyst-stage embryos [1].
The abilities of ES cells to undergo indefinite self-renewal
in vitro and to produce derivative lineages of all three
embryonic germ layers in vitro and in vivo make them
highly prized in both clinical and research settings [2].
ES, or ES-like, cells have thus far been derived from a
number of mammalian species, including the mouse [3],
rat [4], bovine [5], sheep [6], pig [7], rhesus macaque [8],
crab-eating macaque [9], marmoset [10] and human [11].
Apodemus sylvaticus is a common rodent species found
throughout Europe. A. sylvaticus has a gross appearance
similar to that of the laboratory mouse. The rearing con-
ditions are also quite similar to those of the mouse. How-
ever, the superficial resemblance between A. sylvaticus
and the laboratory mouse belies the rather deep evolu-
tionary divide separating these two species. The combi-
nation of these properties--that is, the similar rearing
conditions and large evolutionary divergence--makes A.
sylvaticus highly attractive as a potential model organism
that could perhaps complement the mouse in many stud-
ies. Unlike the mouse, however, there is a dearth of
knowledge and reagents related to A. sylvaticus. One
major step in filling this gap is the generation of ES cells
for this species. Recently, we reported the successful
establishment of an ES cell line from A. sylvaticus [12],
named AS-ES1 cells. This cell line has proliferated con-
tinuously for over 6 months with a normal karyotype. It
expresses a variety of markers associated with the undif-
ferentiated state and has the ability to produce lineages of
all three germ layers in vitro and in vivo. However, there
are some characteristic differences between AS-ES1 and
mouse ES cells. For example, AS-ES1 cells do not express
stage specific embryonic antigen-1 (SSEA-1), whereas
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mouse ES cells do. Furthermore, the AS-ES1 cell line pro-
liferates faster than specific mouse ES cell lines. There-
fore, as a new species of ES cell line, the basic
characteristics of AS-ES1 cells need to be studied further,
including specific lineage differentiation.
Mouse ES cells were first established in 1981. Since
then, many studies have been carried out regarding the
three lineages differentiation of mouse ES cells in vitro.
For mesodermal differentiation of mouse ES cells in vitro,
different research groups have generated a variety of cell
types, such as adipocytes [13,14], osteoblasts [15-19],
chondrocytes [20-22] and cardiomyocytes [23,24], among
others. Through this research, some pivotal agents that
play an important role in the process of mesodermal dif-
ferentiation of mouse ES cells have been discovered.
However, it was not known whether those agents and dif-
ferentiation methods could work with AS-ES1 cells.
Herein we report that AS-ES1 cells treated with retin-
oic acid (RA) or 5-azacytidine (5-AZA) at the embryoid
body (EB) stage, with the addition of various specific fac-
tors and reagents to the medium during EB attachment,
generated multiple mesodermal lineages in vitro, includ-
ing adipocytes, osteoblasts, chondrocytes and cardio-
myocytes.
Results
AS-ES1 cells maintained their undifferentiated state and 
generated embryoid bodies (EBs) in vitro
AS-ES1 cells maintained their undifferentiated state
when cultured on mouse embryonic fibroblast (MEF)
cells. The ES clones had a dome-like shape with smooth
and clearly defined borders (Fig. 1A). The ES cells
between P50 and P60 were dissociated to single cells for
forming EBs. After hanging drop culture for 2 days, 80%
of the ES cell clumps began to organize into three-dimen-
sional aggregates. After 7 days of culture, the aggregates
grew into spherical EB-like structures with a uniform size
and central transparency (Fig. 1B).
AS-ES1 cells were capable of in vitro adipogenesis, 
osteogenesis and chondrogenesis
Adipocytes, osteoblasts and chondrocytes derived from
AS-ES1 cells emerged in EB outgrowths following in vitro
differentiation. Adipocytes contain lipid droplets that can
be easily visualized with oil red O staining. EB outgrowth
cells stained with oil red O were observed as a large adi-
pocyte colony that developed in the outgrowth of the
aggregate (Fig. 2A, a and 2A, b). Calcium deposition,
detected by alizarin red, also occurred in EB outgrowth
areas (Fig. 2A, c and 2A, d). These calcium nodules are
secreted by osteoblasts. Light- to dark-red/purple regions
became noticeable within the outgrowth cells with tolui-
dine blue staining. This is indicative of cartilage-like
Figure 1 Apodemus sylvaticus ES cell and embryoid body. Phase-
contrast images of Apodemus sylvaticus ES cell colonies (A) and em-
bryoid bodies after 7 days of formation (B). Scale bar, 100 μm.
Figure 2 Adipogenesis, osteogenesis and chondrogenesis of 
Apodemus ES cells in vitro. Histochemistry and immunofluorescence 
staining illustrates adipogenesis, osteogenesis and chondrogenesis of 
Apodemus ES cells. (A) EB outgrowths stained by Oil Red O, (a, b) Aliza-
rin Red, (c, d) or Toluidine Blue (e), EB outgrowths simultaneously 
stained for positive collagen II expression (f, Red: anti-collagen II an-
tibody; Blue: Hoechst 33342). (B) Representative image of RT-PCR of 
adipogenesis, osteogenesis and chondrogenesis specific genes, ex-
pressed on day 28 of differentiation. Numbers 1, 2 and 3 represent 
three independent experiments in adipogenesis, osteogenesis and 
chondrogenesis. Scale bar, 100 μm.Wang et al. BMC Cell Biology 2010, 11:42
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extracellular matrix accumulation. The cartilage nodules
consisted of well separated round cells, and large extra-
cellular spaces were stained metachromatically with tolu-
idine blue (Fig. 2A, e). To further confirm
chondrogenesis, EB outgrowths were stained with an
anti-collagen IIantibody. The extracellular matrix posi-
tively expressed collagen II (Fig. 2A, f).
The percentage of positive cells stained by oil red O,
alizarin red, toluidine blue or anti-collagen IIantibody
differed. The proportion of positive cells in chondrogene-
sis was the greatest (toluidine blue, 20.69 ± 1.16%; anti-
collagen IIantibody, 30.46 ± 1.87%), whereas the propor-
tion of positive cells in adipogenesis (8.98 ± 0.89%) was
similar to that in osteogenesis (9.05 ± 0.88%).
Expression of specific genes for adipogenesis, osteogen-
esis and chondrogenesis was investigated by Reverse
Transcription-Polymerase Chain Reaction (RT-PCR)
(Fig. 2B). We analyzed expression levels for genes includ-
ing the adipocyte lipid binding protein (ALBP), peroxi-
some proliferative-activated receptor γ2 (PPARγ2),
CCAAT/enhancer binding protein α (C/EBPα), Runx2,
Osteopontin, Sox9 and Col2a1. RT-PCR of β-actin and
undifferentiated AS-ES1 cells were included as positive
and negative controls, respectively.
Generation of cardiomyocytes by AS-ES1 cells
Besides adipocyte, osteoblast and chondrocyte genera-
tion, under cardiomyocyte differentiation conditions
beating cells were observed in EB outgrowths as early as
16 days after plating. As differentiation proceeded, more
and more beating cells could be observed by microscopy
(see Additional file 1: Movie for the beating cells).
Twenty-one days after plating, we performed immunos-
taining for cardiac muscle markers. AS-ES1 cell-derived
cardiomyocytes were positively stained with anti-desmin
(Fig. 3A, a), anti-sarcomeric α-actinin (Fig. 3A, d), anti-
cardiac myosin heavy chain (MHC) (Fig. 3A, g) and anti-
cardiac troponin I (Fig. 3A, j) antibodies. The cardiomyo-
cytes exhibited striations and staining patterns of cyto-
plasmic localization that are characteristic of the
sarcomeric organization of muscle cells. The numbers of
po s i t i v e  c e l l s  s t a i n e d  b y  t h e  f o u r  a n t i bod i e s  w e r e  a n a -
lyzed. The proportions were as follows: anti-desmin anti-
body, 25.19 ± 2.19%; anti-sarcomeric α-actinin antibody,
10.12 ± 1.18%; anti-MHC antibody, 15.16 ± 1.41% and
anti-cardiac troponin I antibody, 16.97 ± 0.92%. Expres-
sion of other cardiac markers GATA-4 and β-myosin
heavy chain (β-MHC) was also determined by RT-PCR
(Fig. 3B).
Discussion
In our previous research, AS-ES1 cells spontaneously dif-
ferentiated into cells of three germ lineages in vitro and
produced healthy chimeras bearing extensive contribu-
tions in all major organs [12]. As a new ES cell line, AS-
ES1 cells require more experimentation to discover their
features. In this paper, we focused on the formation of
specific mesodermal cells, derived from AS-ES1 cells,
cultured with various factors and reagents in vitro,
including dexamethasone, β-glycerophosphate, ascorbic
acid, insulin and transforming growth factor (TGF) β1.
First, we treated EBs of AS-ES1 cells with RA for 3 days,
which was previously reported to induce the develop-
ment of mesenchymal cell lineages from mouse ES cells
[13,25]. The distinctive effect of RA on ES cell differentia-
tion is uncertain. It was reported that RA enhances neu-
ral crest generation, a major source of mesenchymal
elements in RA-treated EBs, but not mesoderm develop-
ment directly, to drive the formation of mesodermal type
cells [18]. However, RA suppresses cardiomyocyte forma-
tion [13,25]. Thus, 5-AZA, which has previously been
employed for the formation of cardiomyocytes derived
from ES cells [24,26], was used to replace RA for cardio-
myocyte differentiation in this study.
Figure 3 Cardiomyocytes derived from Apodemus ES cell in vitro. 
Immunofluorescence staining illustrated cardiomyocytes derived from 
Apodemus ES cells. (A) Cells were stained with anti-desmin (a), anti-sar-
comeric α-actinin (d), anti-cardiac myosin heavy chain (g) or anti-cardi-
ac troponin I (j) antibodies as indicated. Hoechst 33342 was used to 
stain nuclei (b, e, h and k). Figures c, f, i and l are merged images. (B) 
Expression of cardiac markers (GATA-4 and β-MHC) was determined by 
RT-PCR. Numbers 1, 2 and 3 represent three independent experi-
ments in cardiomyocyte formation. Scale bar, 100 μm.Wang et al. BMC Cell Biology 2010, 11:42
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After EB formation, during the EB attachment stage,
various factors and reagents, such as dexamethasone, β-
glycerophosphate and TGFβ1, have been used to enhance
differentiation. These factors and reagents were impor-
tant elements for mesoderm differentiation of mouse ES
cells into adipocytes, osteoblasts or other types of meso-
dermal cells [13,15-18]. In our experiment, we obtained
four types of mesodermal cells separately by applying
similar factors and reagents. With cardiomyocyte differ-
entiation, we preferred a simple compound, ascorbic acid,
rather than 5-AZA, because of 5-AZA cytotoxicity. The
Takahashi group [23] screened a broad range of com-
pounds and determined that ascorbic acid markedly
increased the efficiency of cardiac differentiation from
mouse ES cells. In addition, Sato's group [27] demon-
strated that ascorbic acid enhanced the differentiation of
ES cells into cardiomyocytes through collagen synthesis.
From quantitative data, we could estimate that the yield
of the four cell types--adipocytes, osteoblasts, chondro-
cytes and cardiomyocytes--was 10-30% of the total cell
number. The proportions were similar to those of the
four cell types derived from mouse ES cells [18].
Conclusions
This study demonstrated that AS-ES1 cells could be
induced to differentiate into mesodermal lineages by a
combination of growth factors and chemicals and pro-
vides more information to further understand the differ-
entiation characteristics of AS-ES1 cells.
Methods
AS-ES1 Cell Culture
AS-ES1 cells were cultured on MEF cells mitotically inac-
tivated by 55-gray γ-irradiation, as previously described
[12]. The ES cell medium contained high-glucose DMEM
(Hyclone Laboratories Inc., Logan, UT, USA) supple-
mented with 10% fetal bovine serum (Hyclone), 103 units/
ml recombinant murine leukemia inhibitory factor (LIF)
(Chemicon International Inc., Temecula CA, USA), 0.1
mM b-mercaptoethanol (Sigma, St. Louis MO, USA), 1
mM sodium pyruvate (Gibco/Invitrogen, Grand Island
NY, USA), 1× nonessential amino acids (Sigma) and 1×
penicillin/streptomycin (Gibco/Invitrogen). The AS-ES1
cells were kept at 37°C in a humidified atmosphere with
5% CO2 and were passaged every 2-3 days.
Embryoid Body (EB) Formation and Differentiation Media
AS-ES1 cells were dissociated with 0.25% trypsin/1 mM
EDTA (Gibco/Invitrogen) and resuspended in EB
medium. This medium consisted of high-glucose DMEM,
20% fetal bovine serum, 1× nonessential amino acids and
1× penicillin/streptomycin. Hanging drops containing 4-
5 × 103 cells in 20 μl of EB medium were maintained for 2
days on the lid of bacteriological dishes filled with phos-
phate-buffered saline (PBS). The EBs were then trans-
ferred into bacteriological dishes and maintained for 3
days in suspension in EB medium supplemented with
either 10-7 M all-trans retinoic acid (RA, Sigma) [13,18]
for adipo-, osteo- and chondrogenesis, or 10-6 M 5-azacy-
tidine (5-AZA, Sigma) [24] for cardiomyocyte generation.
The medium was changed daily. EBs were maintained for
2 more days in suspension in EB medium and were then
a l l o w e d  t o  s e t t l e  o n t o  2 %  g e l a t i n - c o a t e d  p l a t e s  i n  t h e
presence of various differentiation media. The differenti-
ation media contained high-glucose DMEM, 10% fetal
bovine serum and 1× penicillin/streptomycin supple-
mented with the following reagents: 1 μm/L dexametha-
sone, 0.2 mM indomethacin, 0.5 mM 3-isobutyl-1-
methylxanthine (IBMX) and 10 μg/ml insulin for adipo-
genesis [14,28]; 0.1 μm/L dexamethasone, 0.2 mM ascor-
bic acid and 10 mM β-glycerophosphate for osteogenesis
[15,17]; 10 ng/ml transforming growth factor (TGF) β1
and fetal bovine serum reduced to 3% for chondrogenesis
[18,29]; and 0.4 mM ascorbic acid for cardiomyocyte for-
mation [23]. TGFβ1 was purchased from PeproTech EC
(London, UK) and the other reagents were obtained from
Sigma. All of the differentiation media were changed
every three days.
Histochemical Staining
The day of EB initial formation represented day 0. EB out-
growths induced for 28 days were fixed by 10% neutral
formaldehyde for 20 min, washed with dH2O and then
processed as follows for the different stains. The results
of the histochemical staining were investigated under an
inverted microscope (Olympus, Japan).
Oil Red O staining: samples were incubated with 2% oil
red O (Sigma) in 60% iso-propyl alcohol for 40 min. To
avoid non-specific staining, the samples were incubated
with 60% iso-propyl alcohol for 2 min and washed with
dH2O four times.
Alizarin Red staining: specimens were incubated with
40 mM alizarin red (Sigma) in dH2O for 20 min and
washed with dH2O four times.
Toluidine Blue staining: specimens were incubated with
1% toluidine blue (Sigma) for 2 h, washed with 95% etha-
nol one time and rinsed in dH2O four times.
Immunofluorescence Staining for Cells
EB outgrowth cells were fixed with 4% paraformaldehyde
in PBS, permeabilized by 0.1% Triton X-100 for 30 min
and blocked with 10% normal goat serum in PBS for 1 h.
The cells were first incubated with primary antibodies
against desmin (Neomarkers, Fremont CA, USA, 200×
dilution), sarcomeric α-actinin (Sigma, 400× dilution),
cardiac myosin heavy chain (Chemicon, 100× dilution),
cardiac troponin I (Chemicon, 100× dilution) or collagen
II (Rockland Inc., Gilbertsville PA, USA, 200× dilution) atWang et al. BMC Cell Biology 2010, 11:42
http://www.biomedcentral.com/1471-2121/11/42
Page 5 of 6
4°C overnight, followed by incubation with Cy3-conju-
gated goat anti-mouse IgG or goat anti-rabbit IgG
(Southern Biotech, Birmingham AL, USA) for 1 h at
room temperature. The specimens were mounted in a
vectashield with Hoechst 33342 (Sigma) and observed
under a fluorescence microscope (Olympus).
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Assay
Total RNA from EB outgrowths was extracted using TRI-
zol (Gibco/Invitrogen). The first strand complementary
DNA was synthesized using Sensiscript Reverse Tran-
scriptase (Qiagen GmbH, Hilden, Germany) followed by
PCR amplification. The primer sequences and PCR prod-
uct sizes were: β-actin (F-AGAAGATCTGGCACCA-
CACC, R-TACGACCAGAGGCATACAGG; 198 bp),
ALBP (F-TTGGTCACCATCCGGTCAGA, R-TTCCAC-
CACCAGCTTGTCAC; 207 bp), PPARγ2 (F-ATCATC-
TACACGATGCTGGCC, R-CTCCCTGGTCATGAATC
CTTG; 80 bp), C/EBPα (F-CGCAAGAGCCGAGA-
TAAAGC, R-GCGGTCATTGTCACTGGTCA; 80 bp),
Runx2 (F-CCTGAACTCTGCACCAAGTC, R-GAG-
GTCGCAGTGTCATCATC; 234 bp), Osteopontin (F-
TCTCCTTGCGCCACAGAATG, R-TCCTTAGACT-
CACCGCTCTT; 398 bp), Sox9 (F-GCAGACCAGTAC-
CCGCATCT, R-CTCGCTCTCGTTCAGCAGC; 80 bp),
Col2a1 (F-CCGTCATCGAGTACCGATCA, R-CAGGT-
CAGGTCAGCCATTCA; 228 bp), GATA-4 (F-CTGT-
CATCTCACTCTGGGCA, R-CCAAGTCCGAGCAGG
AATTT; 256 bp), β-MHC (F-ACCCCTACGATTAT-
GCG, R-GTGACGTACTCGTTGCC; 319 bp). The
amplification fragments were analyzed on a 2% agarose
gel. Imaging and scanning densitometry quantification
were performed on a Kodak image station 2000R (Kodak,
Rochester NY, USA).
Positive cell staining counts and statistical analyses
All experiments of adipogenesis, osteogenesis, chondro-
genesis and cardiomyocyte formation were performed at
least three times. Data for percentage of positive cells
were expressed as mean ± standard deviation and ana-
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